General Information
DRACP ID DRACP06002
Peptide Name
Sequence KALKALKKALKALKDGR
Sequence Length 17
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Membrane-targeted Lipopeptides
Activity Information
Hemolytic Activity Low hemolysis
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification C8H15O
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C84H158N26O20
Absent amino acids CEFHIMNPQSTVWY
Common amino acids K
Mass 213794
Pl 11.46
Basic residues 7
Acidic residues 1
Hydrophobic residues 8
Net charge 6
Boman Index -2908
Hydrophobicity -55.29
Aliphatic Index 115.29
Half Life
Mammalian: 1.4 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN114805493A
Patent Title Preparation and anti-tumor effect of RGD/KLA integrated lipopeptide
Other Iinformation Not available
Other Published ID Not available